Blood Cancer Journal
Overview
Blood Cancer Journal is a peer-reviewed open-access journal that focuses on all aspects of hematological malignancies. It publishes high-quality research articles, reviews, and case reports, providing a platform for the dissemination of cutting-edge knowledge in the field. With a multidisciplinary approach, the journal aims to advance understanding, diagnosis, and treatment of blood cancers, fostering collaboration among researchers, clinicians, and scientists worldwide.
Details
Details
Abbr.
Blood Cancer J
Start
2011
End
Continuing
Frequency
Irregular
e-ISSN
2044-5385
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 4647
76
SJR / Ranks: 375
3974
CiteScore / Ranks: 763
13.40
JIF / Ranks: 296
12.8
Recent Articles
11.
Thiele J, Kvasnicka H, Gianelli U, Arber D, Tefferi A, Vannucchi A, et al.
Blood Cancer J
. 2025 Mar;
15(1):31.
PMID: 40038244
A lively discussion persists regarding the diagnostic criteria for essential thrombocythemia (ET), primary myelofibrosis (PMF) and polycythemia vera (PV), particularly in relation to early/pre-fibrotic myelofibrosis (pre-PMF), a disease entity initially...
12.
Dulobdas V, Kirkwood A, Serpenti F, Gautama B, Panopoulou A, Mathew A, et al.
Blood Cancer J
. 2025 Mar;
15(1):30.
PMID: 40032870
CAR T-cell manufacturing failure (MF) is a situation where the manufacturing process fails to yield a product or results in one which is out-of-specification (OOS). We conducted a multicentre retrospective...
13.
Summerer I, Walter W, Meggendorfer M, Haferlach T, Dicker F, Hutter S, et al.
Blood Cancer J
. 2025 Mar;
15(1):29.
PMID: 40032819
No abstract available.
14.
Fathima S, Alsugair A, He R, Mangaonkar A, Begna K, Pardanani A, et al.
Blood Cancer J
. 2025 Mar;
15(1):28.
PMID: 40025027
Recent reports suggest a favorable prognosis for PHF6 mutation (PHF6) in chronic myelomonocytic leukemia (CMML) and unfavorable in acute myeloid leukemia (AML). We accessed 176 consecutive patients with a spectrum...
15.
Mannelli F, Piccini M, Frigeni M, Gianfaldoni G, Bencini S, Salmoiraghi S, et al.
Blood Cancer J
. 2025 Feb;
15(1):27.
PMID: 40021639
No abstract available.
16.
Kotecha R, Trinder S, Hughes A, Mullin B, Rashid S, Yuan J, et al.
Blood Cancer J
. 2025 Feb;
15(1):25.
PMID: 40016188
No abstract available.
17.
Luchinin A, Gevorkyan T, Semenova A
Blood Cancer J
. 2025 Feb;
15(1):26.
PMID: 40016177
No abstract available.
18.
Liu Y, Zhang Q, Lv F, Liu X, Ji D, Xia Z, et al.
Blood Cancer J
. 2025 Feb;
15(1):24.
PMID: 40000615
No abstract available.
19.
Simhal A, Firestone R, Oh J, Avutu V, Norton L, Hultcrantz M, et al.
Blood Cancer J
. 2025 Feb;
15(1):22.
PMID: 39979284
Current prognostic scores in multiple myeloma (MM) currently rely on disease burden and a limited set of genomic alterations. Some studies have suggested gene expression panels may predict clinical outcomes,...
20.
Kittai A, Huang Y, Miller S, Allan J, Bhat S, Bond D, et al.
Blood Cancer J
. 2025 Feb;
15(1):23.
PMID: 39979241
No abstract available.